Sonidegib

Sonidegib is a medication used to treat advanced basal cell carcinoma, a type of skin cancer. It works by blocking a specific pathway (the Hedgehog signaling pathway) that helps cancer cells grow and divide. By inhibiting this pathway, sonidegib can slow or stop the tumor's growth. It is typically prescribed when surgery isn’t possible or effective. Patients taking sonidegib should be monitored for side effects, which can include muscle pain, fatigue, and hair loss. Overall, it offers an important targeted therapy option for managing certain skin cancers.